Gossamer Bio, Inc.
GOSS
$0.16
-$0.01-3.38%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 71.45% | 47.13% | 40.23% | -88.01% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 71.45% | 47.13% | 40.23% | -88.01% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 71.45% | 47.13% | 40.23% | -88.01% | -- |
| SG&A Expenses | 116.52% | 16.06% | 10.44% | 0.12% | -9.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.38% | 31.49% | 26.57% | 14.85% | 11.30% |
| Operating Income | -21.89% | -27.44% | -22.76% | -174.42% | 12.27% |
| Income Before Tax | -27.37% | -33.54% | -51.00% | -171.32% | 12.62% |
| Income Tax Expenses | -- | 96.35% | -- | -- | -- |
| Earnings from Continuing Operations | -27.37% | -43.02% | -56.55% | -177.74% | 12.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.37% | -43.02% | -56.55% | -177.74% | 12.62% |
| EBIT | -21.89% | -27.44% | -22.76% | -174.42% | 12.27% |
| EBITDA | -21.89% | -27.80% | -23.53% | -174.06% | 11.74% |
| EPS Basic | -23.41% | -43.00% | -55.40% | -177.39% | 13.03% |
| Normalized Basic EPS | -23.37% | -6.80% | -26.64% | -170.94% | 13.01% |
| EPS Diluted | -23.41% | -43.00% | -55.40% | -178.38% | 13.03% |
| Normalized Diluted EPS | -23.37% | -6.80% | -26.64% | -174.82% | 13.01% |
| Average Basic Shares Outstanding | 3.23% | 0.00% | 0.72% | 0.47% | 0.48% |
| Average Diluted Shares Outstanding | 3.23% | 0.00% | 0.72% | -4.72% | 0.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |